Ranibizumab may help drivers with macular degeneration

NEW YORK (Reuters Health) - In patients with age-related macular degeneration (AMD), ranibizumab (Lucentis, Genentech) seems to improve self-reported driving ability more than sham treatment or photodynamic therapy, according to researchers.

Full Story →